comparemela.com

Latest Breaking News On - Ameritas investment partners - Page 1 : comparemela.com

Short Interest in Enbridge Inc. (NYSE:ENB) Decreases By 72.1%

Enbridge Inc. (NYSE:ENB – Get Free Report) (TSE:ENB) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 22,640,000 shares, a drop of 72.1% from the May 15th total of 81,150,000 shares. Approximately 1.1% of the company’s stock are sold short. Based on an […]

United-states
Canada
Jefferies-financial-group
Ameritas-investment-partners-inc
Baystate-wealth-management
Energy-services
Financial-gravity-asset-management-inc
Enbridge-inc
Financial-private-wealth-inc
Enbridge
Get-free-report

John Zupo Sells 5,017 Shares of The Vita Coco Company, Inc. (NASDAQ:COCO) Stock

The Vita Coco Company, Inc. (NASDAQ:COCO – Get Free Report) Director John Zupo sold 5,017 shares of Vita Coco stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $27.62, for a total transaction of $138,569.54. Following the sale, the director now directly owns 8,247 shares […]

United-states
Canada
New-york
Piper-sandler
Asia-pacific
John-zupo
Vita-coco
Financial-services-group-inc
Nasdaq
Vita-coco-company-inc
Ameritas-investment-partners-inc
Vita-coco-company-profile

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 5.4%

Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) was down 5.4% during trading on Tuesday . The stock traded as low as $34.87 and last traded at $34.91. Approximately 506,654 shares changed hands during mid-day trading, a decline of 38% from the average daily volume of 814,073 shares. The stock had previously closed at $36.92. […]

Canada
Cantor-fitzgerald
Nasdaq
Ameritas-investment-partners-inc
Headlands-technologies
Canada-life-assurance
Celldex-therapeutics-company-profile
Celldex-therapeutics
Allspring-global-investments-holdings
Celldex-therapeutics-inc
Get-free-report

Argus Upgrades Central Garden & Pet (NASDAQ:CENTA) to "Strong-Buy"

Central Garden & Pet (NASDAQ:CENTA – Get Free Report) was upgraded by stock analysts at Argus to a “strong-buy” rating in a report issued on Tuesday, Zacks.com reports. A number of other research analysts also recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Central Garden & Pet from […]

Colorado
United-states
Johnd-walker
Howard-machek
Public-employees-retirement-association-of-colorado
Central-garden-pet-company
Securities-exchange-commission
Brighton-jones
Jpmorgan-chase-co
Sg-americas-securities
Central-garden-pet-company-profile
Ameritas-investment-partners-inc

CG Oncology (NASDAQ:CGON) Given "Buy" Rating at HC Wainwright

CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $75.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 131.48% from the […]

Cg-oncology-inc
Ameritas-investment-partners-inc
Vanguard-group-inc
Timessquare-capital-management
Cantor-fitzgerald
Capstone-investment-advisors
Goldman-sachs-group
Morgan-stanley
Get-free-report
Financial-markets
Investment-advisors

vimarsana © 2020. All Rights Reserved.